Kampala — Ugandan pharmaceutical manufacturer Dei Biopharma led by scientist Dr. Matthias Magoola has received a significant boost in its bid to enter the highly regulated United States drug market...
KAMULI, Uganda — President Museveni on Thursday November 20, launched the Dei Biopharma Advanced Agro-Processing and Biotech Park in Namasagali, Kamuli District, a project led by Uganda scientist Dr. Matthias...
Durban City, South Africa – Dei BioPharma Founder Dr. Matthias Magoola, has announced at a meeting of the African Center for Disease Control (CDC), that the Ugandan firm has now...
KAMPALA - President Yoweri Museveni has indicated that the Ugandan economy will rip big from the knowledge economy, including biotechnology breakthroughs led by Dr. Matthias Magoola, the Founder of pharmaceutical...
KAMPALA, Uganda — The U.S. Food and Drug Administration (FDA) has agreed to waive clinical efficacy testing requirements for two of Dei Biopharma’s cancer therapies, including pembrolizumab (Keytruda) and trastuzumab...
BRAMPTON, Ontario — Dr. Matthias Magoola, a Ugandan scientist and founder of Dei Biopharma Ltd., has been honored with the Lifetime Achievement Award at the 2025 Sankofa Royale Award Gala...
